CY1935A - Novel vaccine and method therefor - Google Patents

Novel vaccine and method therefor

Info

Publication number: CY1935A
Authority: CY; Cyprus
Prior art keywords: method therefor; novel vaccine; detoxified; pertussis toxin; vaccine
Prior art date: 1990-02-12

Application number

CY193591A

Other languages

English (en)

Inventor

Carine Capiau

Jean Petre

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-12

Filing date

1991-02-07

Publication date

1991-02-07

1991-02-07 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

1991-02-07 Publication of CY1935A publication Critical patent/CY1935A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Compounds Of Unknown Constitution (AREA)

CY193591A 1990-02-12 1991-02-07 Novel vaccine and method therefor CY1935A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US47909890A	1990-02-12	1990-02-12
PCT/EP1991/000257 WO1991012020A1 (en)	1990-02-12	1991-02-07	Novel vaccine and method therefor

Publications (1)

Publication Number	Publication Date
CY1935A true CY1935A (en)	1991-02-07

Family

ID=23902647

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY193591A CY1935A (en)	1990-02-12	1991-02-07	Novel vaccine and method therefor

Country Status (17)

Country	Link
EP (1)	EP0515415B1 (da)
JP (1)	JP3035712B2 (da)
KR (1)	KR100202052B1 (da)
AT (1)	ATE129159T1 (da)
AU (1)	AU646019B2 (da)
CA (1)	CA2075711C (da)
CY (1)	CY1935A (da)
DE (1)	DE69113991T2 (da)
DK (1)	DK0515415T3 (da)
ES (1)	ES2080941T3 (da)
GR (1)	GR3018440T3 (da)
HK (1)	HK1004524A1 (da)
IE (1)	IE70672B1 (da)
NZ (1)	NZ237069A (da)
PT (1)	PT96723B (da)
WO (1)	WO1991012020A1 (da)
ZA (1)	ZA91947B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122010000015I1 (de)	1992-05-23	2010-07-08	Glaxosmithkline Biolog Sa	Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten
GB9216351D0 (en) *	1992-07-31	1992-09-16	Wellcome Found	Vaccine production
JP4601823B2 (ja) *	1998-09-01	2010-12-22	メリオンリサーチスリーリミテッド	経口ワクチン組成物
AU769539B2 (en) *	1999-01-29	2004-01-29	Zoetis Services Llc	Adjuvants for use in vaccines
GB0313916D0 (en)	2003-06-16	2003-07-23	Glaxosmithkline Biolog Sa	Vaccine composition
BR112014017898B1 (pt)	2012-02-01	2021-10-13	Glaxosmithkline Biologicals S.A.	Processo de fermentação
JP2015525794A (ja)	2012-08-06	2015-09-07	グラクソスミスクラインバイオロジカルズソシエテアノニム	乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
US20140037680A1 (en)	2012-08-06	2014-02-06	Glaxosmithkline Biologicals, S.A.	Novel method
BR112015021523A8 (pt)	2013-03-08	2021-06-29	Crucell Holland Bv	composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
US9849066B2 (en)	2013-04-24	2017-12-26	Corning Incorporated	Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
MX2016001695A (es)	2013-08-05	2016-05-02	Glaxosmithkline Biolog Sa	Composiciones inmunogenas de combinacion.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4070454A (en) *	1973-05-04	1978-01-24	Agence Nationale De Valorisation De La Recherche (Anvar)	Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) *	1980-09-12	1982-03-25	Takeda Chem Ind Ltd	Preparation of pertussis toxoid
GB8601279D0 (en) *	1986-01-20	1986-02-26	Public Health Lab Service	Purification of pertussis antigens
US4888169A (en) *	1986-10-14	1989-12-19	Norden Laboratories, Inc.	Bordetella Bronchiseptica vaccine
AU5027890A (en) *	1989-02-10	1990-09-05	Genesit Oy	A method for producing pertussis toxin subunits

1991
- 1991-02-07 ES ES91903336T patent/ES2080941T3/es not_active Expired - Lifetime
- 1991-02-07 JP JP03503734A patent/JP3035712B2/ja not_active Expired - Lifetime
- 1991-02-07 DK DK91903336.5T patent/DK0515415T3/da active
- 1991-02-07 WO PCT/EP1991/000257 patent/WO1991012020A1/en active IP Right Grant
- 1991-02-07 EP EP91903336A patent/EP0515415B1/en not_active Expired - Lifetime
- 1991-02-07 CY CY193591A patent/CY1935A/xx unknown
- 1991-02-07 AU AU72110/91A patent/AU646019B2/en not_active Expired
- 1991-02-07 AT AT91903336T patent/ATE129159T1/de not_active IP Right Cessation
- 1991-02-07 CA CA002075711A patent/CA2075711C/en not_active Expired - Lifetime
- 1991-02-07 DE DE69113991T patent/DE69113991T2/de not_active Expired - Lifetime
- 1991-02-08 IE IE42491A patent/IE70672B1/en not_active IP Right Cessation
- 1991-02-08 ZA ZA91947A patent/ZA91947B/xx unknown
- 1991-02-08 PT PT96723A patent/PT96723B/pt not_active IP Right Cessation
- 1991-02-11 NZ NZ237069A patent/NZ237069A/en unknown
1992
- 1992-08-11 KR KR1019920701931A patent/KR100202052B1/ko not_active IP Right Cessation
1995
- 1995-12-15 GR GR950403570T patent/GR3018440T3/el unknown
1998
- 1998-04-28 HK HK98103622A patent/HK1004524A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69113991T2 (de)	1996-03-21
JPH05503936A (ja)	1993-06-24
CA2075711A1 (en)	1991-08-13
AU7211091A (en)	1991-09-03
JP3035712B2 (ja)	2000-04-24
KR920703099A (ko)	1992-12-17
EP0515415B1 (en)	1995-10-18
IE910424A1 (en)	1991-08-14
PT96723A (pt)	1991-10-31
ES2080941T3 (es)	1996-02-16
WO1991012020A1 (en)	1991-08-22
DE69113991D1 (de)	1995-11-23
DK0515415T3 (da)	1995-11-27
ZA91947B (en)	1992-01-29
NZ237069A (en)	1993-07-27
PT96723B (pt)	1998-07-31
GR3018440T3 (en)	1996-03-31
EP0515415A1 (en)	1992-12-02
ATE129159T1 (de)	1995-11-15
KR100202052B1 (ko)	1999-06-15
IE70672B1 (en)	1996-12-11
AU646019B2 (en)	1994-02-03
HK1004524A1 (en)	1998-11-27
CA2075711C (en)	2000-11-07

Publication	Publication Date	Title
DE69022106D1 (de)	1995-10-12	Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis.
NO165478C (no)	1991-02-20	Fremgangsmaate for fremstilling av antigeniske preparater.
GR3018440T3 (en)	1996-03-31	Novel vaccine and method therefor.
ZA874064B (en)	1988-04-27	Method of preparing toxoid
MX9200793A (es)	1992-08-01	Tetrahidropirinas y metodo para su preparacion.
NO872919L (no)	1988-10-25	Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
CA2004206A1 (en)	1990-05-29	Method for preparing pertussis toxin toxoid
HK1004555A1 (en)	1998-11-27	Process
ZA892908B (en)	1990-04-25	Pertussis toxoid vaccine
ES2036602T3 (es)	1993-06-01	Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
FR2601250B1 (fr)	1989-12-01	Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions.